eptB is a 574-amino acid inner membrane protein encoded by the yhjW (renamed eptB) gene in E. coli . Key features include:
eptB modifies the outer 3-deoxy-D-manno-octulosonic acid (Kdo) residue of lipopolysaccharide (LPS) or lipid A, enabling bacterial adaptation to stressors :
eptB transfers PEtN to lipid A, neutralizing its negative charge. This reduces binding to cationic antimicrobial peptides (CAMPs) like colistin, enhancing resistance .
eptB expression is induced by:
eptB contributes to colistin resistance in E. coli through LPS remodeling. Key findings include:
Recombinant eptB is produced in diverse systems for biochemical studies:
| Host System | Purity | Applications |
|---|---|---|
| E. coli | ≥85% (SDS-PAGE) | Enzymatic assays, structural studies |
| Yeast/Mammalian cells | Variable | Functional studies requiring post-translational modifications |
Full-length eptB (1–563 aa)
Partial fragments (e.g., lipid A-binding domains)
Tag-free versions for native conformation studies
Structural Elucidation: High-resolution crystallography to map PEtN-binding sites.
Inhibitor Development: Targeting eptB’s Ca²+-binding pocket or PEtN transfer mechanism.
Diagnostic Biomarkers: Monitoring eptB expression in clinical isolates for resistance surveillance.
KEGG: ecj:JW5660
STRING: 316385.ECDH10B_3725
EptB (formerly called YhjW) is an enzyme in Escherichia coli that catalyzes the transfer of phosphoethanolamine (PEtN) groups to specific molecules in the bacterial cell envelope. Specifically, EptB modifies the outer Kdo (3-deoxy-D-manno-octulosonic acid) residue of lipopolysaccharide (LPS) with phosphoethanolamine, using phosphatidylethanolamine as a precursor . This modification plays a significant role in bacterial resistance to antimicrobial peptides and antibiotics like colistin .
EptB belongs to the YhjW/YjdB/YijP family, which is a subfamily of the larger alkaline phosphatase superfamily. Members of this superfamily share conserved core structures and active-site residues. Their enzymatic mechanisms are thought to involve catalytic cycles of phosphorylation, sulfatation, or phosphonation of conserved Ser/Cys/Thr residues, similar to the reaction scheme proposed for E. coli alkaline phosphatase .
The primary function of EptB is to modify the lipopolysaccharide (LPS) structure by adding phosphoethanolamine to the outer Kdo residue. This modification alters the net charge of the bacterial cell surface, reducing the binding affinity of cationic antimicrobial peptides and certain antibiotics like colistin . EptB encodes Ca2+-induced pEtN which modifies the outer Kdo residue of E. coli LPS, thus leading to colistin resistance .
The eptB gene in E. coli is regulated by various environmental and stress factors. Research suggests that its expression is influenced by calcium levels, as EptB is described as a Ca2+-induced phosphoethanolamine transferase . Additionally, exposure to subinhibitory concentrations of colistin can enhance the expression of eptB, particularly in strains harboring the mcr-1 gene . This suggests a complex regulatory network that responds to both environmental conditions and antibiotic pressure.
Network analysis has shown that eptB is a highly interconnected node in colistin resistance gene networks. It is associated with 26 biological processes grouped into three major categories: lipopolysaccharide metabolic processes, intracellular signal transduction, and oligosaccharide biosynthetic processes . This high connectivity suggests that eptB plays a central role in coordinating cellular responses related to membrane modification and antibiotic resistance.
Methodologically, eptB can be cloned using techniques such as SOE PCR (Splicing by Overlap Extension) with appropriate primers to introduce restriction sites. For expression, the gene can be inserted into vectors like pMMB67EH or pJT19 under inducible promoters . Transformed E. coli strains can be grown to an OD660 of 0.8 and induced with 0.4 mM IPTG or 2 mM m-toluate for approximately 2 hours . Expression can be verified through SDS-PAGE analysis, immunoblotting, and mass spectrometry to confirm protein production and functionality.
EptB specifically catalyzes the transfer of phosphoethanolamine groups to the outer Kdo residue of lipopolysaccharide in E. coli . It uses phosphatidylethanolamine as a donor substrate . Unlike some related enzymes that modify multiple positions in LPS, EptB appears to be relatively specific for the Kdo residue, which is crucial for its role in antimicrobial resistance and membrane modification.
The enzymatic activity of EptB can be assessed through multiple approaches:
Mass spectrometry (MS)-based analysis of lipid A structures, particularly using negative- and positive-ion matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) MS
Comparative analysis of LPS profiles from wild-type and eptB deletion mutants
Immunoblotting to detect mobility shifts in modified LPS components
Functional assays measuring resistance to cationic antimicrobial peptides as an indirect measure of EptB activity
Several factors influence EptB activity in bacterial cells:
Calcium concentration - EptB is described as a Ca2+-induced enzyme
Expression levels of regulatory genes in the LPS modification pathway
Genetic background, including the presence of mcr genes that may enhance eptB expression
EptB contributes to colistin resistance by catalyzing the addition of phosphoethanolamine to the outer Kdo residue of LPS. This modification alters the net charge of the bacterial outer membrane, reducing the binding affinity of colistin, which is a cationic antimicrobial peptide . Research has demonstrated that the expression of eptB is enhanced in colistin-resistant clinical isolates, particularly when exposed to subinhibitory concentrations of colistin .
Studies have shown a significant interplay between chromosomally encoded eptB and the plasmid-mediated mcr-1 gene in colistin resistance. When exposed to subinhibitory concentrations of colistin, E. coli isolates harboring mcr-1 showed enhanced expression of eptB compared to isolates without mcr-1 . This suggests that mcr-1 may potentiate the expression or activity of eptB, creating a synergistic effect that enhances colistin resistance.
The expression of eptB in colistin-resistant strains can be quantified using real-time PCR (qPCR). RNA is extracted from bacterial cultures, reverse transcribed to cDNA, and then amplified using eptB-specific primers with a reference housekeeping gene like rpsL for normalization . The threshold cycle (ΔΔCt) method can be employed to calculate fold-changes in eptB expression under different conditions, such as with or without colistin exposure .
Table 1: Relationship between eptB expression and colistin resistance factors in E. coli
| Factor | Impact on eptB expression | Effect on colistin resistance | Statistical significance |
|---|---|---|---|
| mcr-1 presence | Enhanced expression | Increased resistance | p < 0.05 |
| Colistin exposure | Upregulation | Enhanced resistance | p < 0.001 |
| Ca2+ concentration | Increased activity | Increased resistance | p < 0.05 |
| Genetic background | Variable expression | Strain-dependent resistance | Variable |
For optimal expression of recombinant EptB:
Use vectors with inducible promoters (IPTG-inducible or m-toluate-inducible systems)
Induce with 0.4 mM IPTG or 2 mM m-toluate for approximately 2 hours
Verify expression through SDS-PAGE, immunoblotting, or mass spectrometry
Creating eptB deletion mutants typically involves:
Designing primers that flank the eptB gene with appropriate restriction sites
Amplifying upstream and downstream regions of the gene
Introducing an antibiotic resistance cassette between these regions
Using homologous recombination to replace the wild-type gene with the deletion construct
Screening transformants for the correct deletion using PCR and sequencing
Verifying phenotypic changes through colistin susceptibility testing and LPS analysis
Several approaches can be employed to study the structure-function relationship of EptB:
Site-directed mutagenesis of conserved residues
Domain swapping with related phosphoethanolamine transferases
Homology modeling based on related enzymes from the alkaline phosphatase superfamily
Expression of truncated versions to identify essential domains
Complementation studies in eptB deletion mutants
Biochemical assays to assess the impact of mutations on enzyme activity
Transcriptomic approaches provide powerful tools for understanding the regulatory networks controlling eptB expression:
RNA-seq analysis comparing wild-type and regulatory mutant strains
Time-course experiments following exposure to different stressors (antibiotics, calcium concentration changes)
Analysis of differential expression patterns in colistin-resistant versus susceptible isolates
Correlation of eptB expression with other genes in the colistin resistance network
Integration of transcriptomic data with network analysis to identify key regulatory nodes
Environmental factors significantly impact eptB expression and function:
Calcium concentration directly influences EptB activity as it is a Ca2+-induced enzyme
Antibiotic pressure, particularly subinhibitory concentrations of colistin, enhances eptB expression
Growth phase and medium composition may affect phosphatidylethanolamine availability
pH changes might impact enzyme activity or substrate binding
Host environment factors during infection could modulate expression patterns
Different heterologous expression systems offer various advantages for studying EptB:
E. coli expression systems provide ease of genetic manipulation but may have different regulatory networks than the native context
P. aeruginosa expression systems have been used successfully for studying EptB function
Cell-free expression systems might allow for direct enzymatic analysis without cellular regulation
Expression in deletion mutants allows for complementation studies to confirm function
Expression with various fusion tags can facilitate purification and localization studies
Mass spectrometry techniques that are particularly effective for analyzing EptB-modified LPS include:
Negative- and positive-ion matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) MS for lipid A structure assessment
Electrospray ionization mass spectrometry (ESI-MS) for detailed structural characterization
Tandem mass spectrometry (MS/MS) for fragmentation analysis to identify specific modification sites
High-resolution MS for accurate mass determination of modified LPS components
Comparative MS profiling of wild-type versus eptB deletion mutants to identify specific changes
Statistical analysis of eptB expression data can be approached through:
Univariable and multivariable logistic regression models to investigate factors associated with expression levels
Calculation of odds ratios (OR) with 95% confidence intervals to quantify relationships
Student's t-test or ANOVA for comparing expression levels between different strains or conditions
Pearson's chi-squared test or Fisher's exact test for categorical variable analysis
Multivariate adjusted models including relevant clinical and demographic characteristics
Table 2: Statistical approaches for analyzing eptB expression data
| Statistical Method | Application | Advantages | Limitations |
|---|---|---|---|
| Univariate analysis | Initial assessment of factors influencing eptB expression | Simple to perform and interpret | Does not account for confounding variables |
| Multivariate analysis | Adjusted assessment of factors | Controls for confounding variables | Requires larger sample sizes |
| Student's t-test | Comparison between two groups | Straightforward for simple comparisons | Limited to two groups only |
| ANOVA | Comparison among multiple groups | Can analyze complex experimental designs | Assumes normal distribution |
| Pearson's chi-squared | Analysis of categorical data | Appropriate for frequency data | Requires adequate sample sizes |
Purifying active recombinant EptB presents several challenges:
Membrane association may require detergent solubilization
Maintaining the correct folding and conformation during purification
Preserving calcium binding capability essential for activity
Preventing aggregation or precipitation during concentration steps
Developing activity assays suitable for purified enzyme rather than whole-cell systems
Stability issues during storage and experimental procedures
EptB and EptA both function as phosphoethanolamine transferases in E. coli but differ in their specificity and cellular roles:
Substrate specificity: EptB primarily modifies the outer Kdo residue of LPS , while EptA targets the 1-phosphate group of lipid A
Regulation: They appear to be regulated by different environmental signals, with EptB being calcium-induced
Contribution to resistance: Both contribute to colistin resistance, but through modifications at different sites of the LPS molecule
Genetic context: They may be found in different genetic contexts, with eptB being highly interconnected in resistance gene networks
EptB belongs to a family of phosphoethanolamine transferases found across many Gram-negative bacteria. Related enzymes include:
These homologs share structural features and belong to the YhjW/YjdB/YijP family, a subfamily of the alkaline phosphatase superfamily .
Several promising research directions for EptB studies include:
Development of specific inhibitors targeting EptB to restore colistin sensitivity
Structural determination through X-ray crystallography or cryo-EM
Investigation of the interplay between different LPS modification systems in antimicrobial resistance
Exploration of EptB's potential role in bacterial virulence beyond antibiotic resistance
Examination of eptB expression patterns during host infection using in vivo models
Application of CRISPR-Cas systems for precise genetic manipulation of eptB in clinical isolates